Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study

被引：24
|
作者：
Wan, Eric Yuk Fai [1 ,2 ,3 ]
Mok, Anna Hoi Ying [3 ]
Yan, Vincent Ka Chun [1 ]
Wang, Boyuan [3 ]
Zhang, Ran [3 ]
Hong, Sabrina Nan [3 ]
Chui, Celine Sze Ling [2 ,4 ,5 ]
Li, Xue [1 ,2 ,6 ]
Wong, Carlos King Ho [1 ,2 ,3 ]
Lai, Francisco Tsz Tsun [1 ,2 ]
Tan, Kathryn Choon Beng [6 ]
Lau, Chak Sing [6 ]
Wong, Ian Chi Kei [1 ,2 ,7 ,8 ,9 ]
Chan, Esther Wai Yin [1 ,2 ,9 ,10 ]
机构：
[1] Univ Hong Kong, Ctr Safe Medicat Practice & Res, Dept Pharmacol & Pharm, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[2] Hong Kong Sci & Technol Pk, Lab Data Discovery Hlth D24H, Hong Kong, Peoples R China
[3] Univ Hong Kong, Dept Family Med & Primary Care, Sch Clin Med, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Peoples R China
[5] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China
[6] Univ Hong Kong, Dept Med, Sch Clin Med, Li Ka Shing Fac Med, Hong Kong, Peoples R China
[7] UCL, Sch Pharm, Res Dept Practice & Policy, London, England
[8] Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, England
[9] Univ Hong Kong, Dept Pharm, Shenzhen Hosp, Shenzhen, Peoples R China
[10] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China
来源：
JOURNAL OF INFECTION | 2022年 / 85卷 / 05期
关键词：
D O I：
10.1016/j.jinf.2022.08.008
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E140 / E144
页数：5
相关论文
共 50 条
  • [1] Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Ye, Xuxiao
    Mok, Anna Hoi Ying
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Li, Philip Hei
    Ma, Tiantian
    Qin, Simon
    Wong, Vincent Kai Chung
    Tsang, Tat Chi
    Tsui, Sik Hon
    Chui, William Chun Ming
    Cowling, Benjamin John
    Leung, Gabriel Matthew
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 2304 - 2314
  • [2] Vaccine Effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 in CKD
    Cheng, Franco Wing Tak
    Yan, Vincent Ka Chun
    Wan, Eric Yuk Fai
    Chui, Celine Sze Ling
    Lai, Francisco Tsz Tsun
    Wong, Carlos King Ho
    Li, Xue
    Chan, Cheyenne I. Ying
    Wang, Boyuan
    Tang, Sydney Chi Wai
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (04): : 418 - 428
  • [3] Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
    Daniel Leung
    Jaime S. Rosa Duque
    Ka Man Yip
    Hung Kwan So
    Wilfred H. S. Wong
    Yu Lung Lau
    Communications Medicine, 3
  • [4] Effectiveness of BNT162b2 and CoronaVac in children and adolescents against SARS-CoV-2 infection during Omicron BA.2 wave in Hong Kong
    Leung, Daniel
    Duque, Jaime S. Rosa S.
    Yip, Ka Man
    So, Hung Kwan
    Wong, Wilfred H. S.
    Lau, Yu Lung
    COMMUNICATIONS MEDICINE, 2023, 3 (01):
  • [5] Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron
    Wei, Yuchen
    Jia, Katherine Min
    Zhao, Shi
    Hung, Chi Tim
    Mok, Chris Ka Pun
    Poon, Paul Kwok Ming
    Leung, Eman Yee Man
    Wang, Maggie Haitian
    Yam, Carrie Ho Kwan
    Chow, Tsz Yu
    Guo, Zihao
    Yeoh, Eng Kiong
    Chong, Ka Chun
    JAMA NETWORK OPEN, 2023, 6 (02)
  • [6] BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
    Tartof, Sara Y.
    Slezak, Jeff M.
    Puzniak, Laura
    Hong, Vennis
    Frankland, Timothy B.
    Ackerson, Bradley K.
    Takhar, Harpreet
    Ogun, Oluwaseye A.
    Simmons, Sarah
    Zamparo, Joann M.
    Jodar, Luis
    McLaughlin, John M.
    LANCET INFECTIOUS DISEASES, 2022, 22 (12): : 1663 - 1665
  • [7] Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
    Tsang, Nicole Ngai Yung
    So, Hau Chi
    Cowling, Benjamin J.
    Leung, Gabriel M.
    Ip, Dennis Kai Ming
    LANCET INFECTIOUS DISEASES, 2023, 23 (04): : 421 - 434
  • [8] Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel
    Glatman-Freedman, Aharona
    Bromberg, Michal
    Hershkovitz, Yael
    Sefty, Hanna
    Kaufman, Zalman
    Dichtiar, Rita
    Keinan-Boker, Lital
    EMERGING INFECTIOUS DISEASES, 2022, 28 (05) : 948 - 956
  • [9] Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study
    Wan, Eric Yuk Fai
    Mok, Anna Hoi Ying
    Yan, Vincent Ka Chun
    Chan, Cheyenne I. Ying
    Wang, Boyuan
    Lai, Francisco Tsz Tsun
    Chui, Celine Sze Ling
    Li, Xue
    Wong, Carlos King Ho
    Lau, Chak Sing
    Wong, Ian Chi Kei
    Chan, Esther Wai Yin
    JOURNAL OF TRAVEL MEDICINE, 2022, 29 (08)
  • [10] Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
    Chaitanya Kurhade
    Jing Zou
    Hongjie Xia
    Hui Cai
    Qi Yang
    Mark Cutler
    David Cooper
    Alexander Muik
    Kathrin U. Jansen
    Xuping Xie
    Kena A. Swanson
    Pei‑Yong Shi
    Nature Communications, 13
12345